Balyasny Asset Management L.P.
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1218710
Chicago, IL
Position in AMLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,302,133
-$3,088,933 QoQ
Shares Held
684,974
-38.1% QoQ
Ownership
0.615%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#34
of 205 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Derivatives in AMLX
reported options exposure · as of Jun 30, 2023CallValue
$9,167,250
CallShares
425,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $126,095,704 across 18 Drug Manufacturers - Specialty & Generic names. AMLX ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
277,821 | $30,821,461 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
309,682 | $19,804,163 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
702,858 | $17,227,049 | |
| 4 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
684,974 | $12,302,133 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
511,336 | $8,196,716 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
218,958 | $7,591,273 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
434,132 | $7,514,824 | |
| 8 | ALKS |
Alkermes plc.
|
142,366 | $7,459,978 |
All Filings in AMLX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,302,133 | 684,974 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $15,391,066 | 1,107,271 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,372,902 | 858,684 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $20,062,944 | 1,476,302 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $525,898 | 148,559 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $189,937 | 50,248 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $164,925 | 50,903 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $43,485 | 22,887 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $289,954 | 19,698 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $12,759,890 | 696,881 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $25,320,009 | 1,173,853 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $9,167,250 | 425,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $12,347,474 | 420,841 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $23,853,183 | 645,553 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,386,052 | 191,334 | Shares | Sole | 2022-11-15 | |
| 2022-03-31 | $808,457 | 62,915 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||